HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...

<?xml encoding="utf-8" ?> A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh ...

In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...

DNA vaccines represent a versatile platform in which plasmid DNA encoding the SARS-CoV-2 spike antigen is delivered into host cells to elicit both antibody-mediated and T cell-mediated immunity. Rapid ...

Vaxxinity Inc (ISIN: US92239B1035) develops innovative synthetic vaccine platforms targeting infectious diseases and oncology. North American investors should monitor clinical milestones and funding ...

A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast cancers in mice. The corresponding study was published in Cell Reports Medicine.

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

Industry leaders and experts from across the globe will meet in Amsterdam to discuss advancements in research and development processes within the evolving vaccine industry. The event will address 12 ...

Rawlings, Minister of Environment, Science and Technology, says Ghana must strengthen its biosafety regulatory system and ...

Vaxcyte remains in focus after recent clinical and pipeline updates around its pneumococcal vaccine program, a key catalyst for a US-listed biotech tied to respiratory disease prevention. PCVX, ...